One month before her 14th birthday, Karyn Glick was diagnosed with chronic myelogenous leukemia. Despite receiving the best treatment available, including a bone marrow transplant, Karyn succumbed to the disease just eleven months later on March 18, 1996. From Karyn’s death and the loss sustained by her family and friends, the Karyn Research Fund was born.

Grants from the Karyn Research Fund are awarded every three years to a Fellow from the Leukemia Society of America. The primary aims of the program are earlier detection, improved treatment, and ultimately, the prevention of pediatric cancers. We hope and anticipate that one day soon a humane and effective cure will be found so that no one else will have to suffer the loss of a beloved child, sibling, friend or valued community member to this terrible disease.